0001474064-12-000059.txt : 20121005 0001474064-12-000059.hdr.sgml : 20121005 20121005160149 ACCESSION NUMBER: 0001474064-12-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121003 FILED AS OF DATE: 20121005 DATE AS OF CHANGE: 20121005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARCEAU ROGER CENTRAL INDEX KEY: 0001451767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 121132425 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2012-10-03 0000890465 NPS PHARMACEUTICALS INC NPSP 0001451767 GARCEAU ROGER 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP & CMO Common Stock 2012-10-03 4 M 0 140625 5.98 A 140625 D Common Stock 2012-10-03 4 S 0 140625 9.5084 D 0 D Stock Option 5.98 2012-10-03 4 M 0 140625 0 D 2009-12-11 2018-12-11 Common Stock 140625 9375 D The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective December 7, 2011. The price shown above represents the weighted average price of the shares sold. The range of sales prices was $9.50 and $9.57. On December 11, 2008, the Reporting Person received a grant of 150,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months on the anniversary date thereafter. Edward Stratemeier as Attorney-in-fact 2012-10-05